|
Market Data
GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global leader in medical technology, specializing in diagnostic imaging, patient monitoring, and pharmaceutical diagnostics. The company's core business revolves around providing innovative products, services, and digital solutions designed to improve patient care across a range of clinical areas. GEHC's diverse portfolio includes advanced imaging systems like CT and MR scanners, ultrasound devices, and patient monitoring equipment. Furthermore, the company develops and markets pharmaceutical diagnostics, including contrast media and radiopharmaceuticals, that enhance the effectiveness of imaging procedures. Operating through four key segments, GE HealthCare Technologies Inc. is committed to advancing healthcare through technological innovation and comprehensive solutions.
GEHC is currently trading at $74.62, giving GE HealthCare Technologies Inc. a market cap of 34.07B and a P/E ratio of 16.3. Today's range spans $73.20–$75.95, with shares opening at $75.20 and moving down $0.04 (0.1%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 66/100.
Over the past year GEHC has traded between $59.95 and $89.77 - the current price is +24.5% off the 52-week low and -16.9% from the high. 29 analysts cover the stock with a Buy consensus and a mean 12-month target of $91.16 (range $75.00–$110.00), implying upside of +22.2%.
The technical picture for GEHC is mixed - score 64/100, HOLD, with the stock at $74.62 (in the middle of its 52-week range) and sentiment bullish at 66/100. For a large-cap in Healthcare with 34.07B in capitalization The current P/E ratio stands at 16.3., this is a fairly common pre-earnings or pre-macro-event posture. Annual range: $59.95–$89.77. Neutral signals at this size often resolve sharply once a catalyst provides directional conviction.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.05 | - | - |
| Q4'25 | $1.43 | $1.44 | +1.0% |
| Q3'25 | $1.05 | $1.07 | +2.2% |
| Q2'25 | $0.92 | $1.06 | +15.4% |
| Q1'25 | $0.91 | $1.01 | +10.6% |
| Q4'24 | $1.26 | $1.45 | +14.8% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $5.0B | - | - |
| Q4'25 | $5.7B | $5.7B | -0.4% |
| Q3'25 | - | $5.1B | - |
| Q2'25 | - | $5.0B | - |
| Q1'25 | - | $4.8B | - |
| Q4'24 | - | $5.3B | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).